Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

AMIFAMPRIDINE vs AMIKACIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

AMIFAMPRIDINE vs AMIKACIN: Safety Overview

Metric AMIFAMPRIDINE AMIKACIN
Total FAERS Reports 2,424 11,312
Deaths Reported 203 2,114
Death Rate 8.4% 18.7%
Hospitalizations 680 4,686
Average Patient Age 62.5 yrs 54.3 yrs
% Female Patients 62.6% 57.4%
FDA Approval Date Nov 28, 2018 Approved Prior to Jan 1, 1982
Manufacturer Catalyst Pharmaceuticals, Inc. Insmed Incorporated
Route ORAL RESPIRATORY (INHALATION)
Marketing Status Prescription Discontinued